Cargando…
Urine Molecular Biomarkers for Detection and Follow-Up of Small Renal Masses
Active surveillance (AS) is the best strategy for small renal masses (SRMs) management; however, reliable methods for early detection and disease aggressiveness prediction are urgently needed. The aim of the present study was to validate DNA methylation biomarkers for non-invasive SRM detection and...
Autores principales: | Žalimas, Algirdas, Kubiliūtė, Raimonda, Žukauskaitė, Kristina, Sabaliauskaitė, Rasa, Trakymas, Mantas, Letautienė, Simona, Kaubrienė, Edita Mišeikytė, Ušinskienė, Jurgita, Ulys, Albertas, Jarmalaitė, Sonata |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9785854/ https://www.ncbi.nlm.nih.gov/pubmed/36555747 http://dx.doi.org/10.3390/ijms232416110 |
Ejemplares similares
-
Clinical Significance of ADAMTS19, BMP7, SIM1, and SFRP1 Promoter Methylation in Renal Clear Cell Carcinoma
por: Kubiliute, Raimonda, et al.
Publicado: (2021) -
The Role of TSHR, PTEN and RASSF1A Promoters’ Methylation Status for Non-Invasive Detection of Papillary Thyroid Carcinoma
por: Klimaitė, Raimonda, et al.
Publicado: (2022) -
Epigenetic Biomarkers of Renal Cell Carcinoma for Liquid Biopsy Tests
por: Kubiliute, Raimonda, et al.
Publicado: (2021) -
Promoter Methylation of PRKCB, ADAMTS12, and NAALAD2 Is Specific to Prostate Cancer and Predicts Biochemical Disease Recurrence
por: Daniunaite, Kristina, et al.
Publicado: (2021) -
Non-Coding RNAs in Glioma
por: Rynkeviciene, Ryte, et al.
Publicado: (2018)